A small transient increase in growth, the midgrowth spurt, has been observe
d in several growth studies in healthy children around the age of 7 yr. Dur
ing this time adrenarche (the physiological increase in adrenal androgen se
cretion) also occurs. Although it is now well established that estrogen, no
t androgen, has a critical role in the male (and female) pubertal growth sp
urt, a direct effect of androgens on growth cannot be excluded. In accordan
ce with published observations that growth is frequently accelerated in inf
ants and young children with late-diagnosed 21-hydroxylase deficiency (befo
re adequate androgen suppression), it has been speculated that the adrenarc
hal increase in adrenal androgen secretion in healthy children could be res
ponsible for the midgrowth spurt. To test this hypothesis we studied long-t
erm serial changes in urinary 24-h excretion rates of dehydroepiandrosteron
e sulfate and total 17-ketosteroid sulfates in a group of healthy children
(n = 12) in which yearly auxological measurements allowed the identificatio
n of a midgrowth spurt. Annual measurements of standing height were perform
ed over periods of 6-9 yr before the onset of puberty. All children collect
ed five to seven serial 24-h urine samples (1-yr intervals) each at the tim
e of anthropometric examination. The peak of the midgrowth spurt was found
to occur at a mean age of 6.8 +/- 1.0 yr. The average height of the midgrow
th peak, i.e. average maximum gain in height velocity, was 0.9 cm/yr. In a
peak-centered examination of individual 24-h excretion rates of dehydroepia
ndrosterone sulfate and 17-ketosteroid sulfates, primarily weak 1-yr change
s in adrenal androgens were observed until the peak was attained. Only afte
r the peak did increments in urinary adrenal androgen output become more pr
onounced.
ANOVA performed on the peak-centered dehydroepiandrosterone sulfate and 17-
ketosteroid sulfate excretion rates revealed a highly significant overall i
ncrease in adrenal androgen secretion from 2 yr before to 2 yr after the mi
dgrowth spurt. After multiple testing, however, significant increments, whe
n compared with the respective preceding androgen excretion levels, were fo
r the first time seen I yr after the midgrowth spurt (dehydroepiandrosteron
e sulfate) or 2 yr later (17-ketosteroid sulfates). In conclusion, our long
itudinal analysis of prepubertal growth and urinary adrenal androgen excret
ion in healthy children disproves the speculation that the midgrowth spurt
is primarily caused by the adrenarchal increase in adrenal androgen secreti
on. However, the present results do not rule out a growth-accelerating effe
ct of clearly higher androgen levels, as in premature adrenarche.